Antiviral Use of FABP4 Modulating Compounds
Copyright © Targeted News Service 2024
2024-11-12
ALEXANDRIA, Virginia, Nov. 12 -- CRESCENTA BIOSCIENCES, Union, New Jersey has been assigned a patent (No. US 12138243 B2, initially filed Dec. 31, 2021) developed by three inventors Emre Koyuncu, Irvine, California; Hahn Kim, Princeton, New Jersey; and Gokhan Hotamisligil, Weston, Massachusetts, for "Antiviral use of FABP4 modulating compounds." . . .